The Beauty of CBD: Cannabis Companies Shift Focus towards Beauty and Wellness
April 10, 2019 10:54 ET | Source: InvestorIdeas.com
This is a repost from an article written in April of this year, but illustrates the global realization of how lucrative the CBD beauty business is, and why as investors, we should all pay attention.
PORT ROBERTS, Wash. and DELTA, British Columbia, April 10, 2019 (GLOBE NEWSWIRE) — Investorideas.com, a leading investor news resource covering cannabis stocks, releases a snapshot looking at the many cannabis companies looking into the CBD beauty and wellness sector and why this sector is gaining such momentum.
According to one report from the GlobalWellnessInstitute, “a wellness mindset is starting to permeate the global consumer consciousness, affecting people’s daily decision-making – whether food purchases, a focus on mental wellness and reducing stress, incorporating movement into daily life, environmental consciousness, or their yearning for connection and happiness,” noted Katherine Johnston, senior research fellow, GWI. “Wellness, for more people, is evolving from rarely to daily, from episodic to essential, from a luxury to a dominant lifestyle value. And that profound shift is driving powerful growth.”
This change in mindset combined with growing interest from large retailers, most recently CVS and Walgreens, is making many companies invest in beauty and wellness.
The most notable is Canopy Growth Corporation (TSX:WEED) (NYSE:CGC) who, along with Sequential Brands Group, Inc., recently announced that Martha Stewart joined the Company in an advisory role to assist with developing and positioning a broad new line of product offerings across multiple categories including beauty and wellness.
With several clinical trials underway, Canopy Growth will be leaning on Martha’s vast knowledge of consumer products while exploring the effectiveness of CBD and other cannabinoids as they relate to improving the lives of both humans and animals.
The Greater Cannabis Company Inc. (OTC: GCAN), a market leader and innovator in the development and commercialization of cannabinoid delivery systems, just recently announced its expansion into the CBD beauty, cosmetics and self-care markets. In addition to its highly bioavailable, orally dissolving transmucosal patch, the Company is now formulating and commercializing a new line of products for CBD-infused cosmetics and skincare applications.
“Consumer demand for CBD-infused beauty products has prompted major retailers such as Walgreens, Sephora and CVS, and major cosmetic brands like Estee Lauder to move into this emerging sector,” said Aitan Zacharin, Chief Executive Officer of The Greater Cannabis Company. “Our unique and proven technology, coupled with the high stability of our product formulations well positions us to meet the market’s demand for CBD-infused beauty and cosmetic products.”
“CBD has a broad range of benefits in topical application, including antioxidants for anti-aging, anti-inflammatory for acne and more,” added Zacharin. “But bioavailability and stability are enormously important to its effectiveness, which is our significant competitive advantage.”
Outside the US, Khiron Life Sciences Corp. (TSXV: KHRN), (OTCQB: KHRNF) announced that it has signed multi-channel distribution agreements for its Kuida® cosmeceutical brand with Fedco and Linio, two of the most prominent consumer distribution channels for wellness and beauty products in Colombia. In combination with the initial product launch through Farmatodo and Farmalisto, it is anticipated that the Kuida® brand will now be made available in up to 78 retail locations and through the country’s leading online portal for beauty products. Initially focused on distribution in Colombia, these agreements create potential for the Company to further expand distribution across other Latin America jurisdictions.
Alvaro Torres, CEO and a Director of Khiron, comments: “These agreements with Fedco and Linio further deliver on our market strategy for Kuida® and provide the flexibility to tap into cross-selling opportunities as consumers increasingly adopt CBD based cosmeceuticals into their skincare regimen. We look forward to working with some of the largest retailers in Colombia as the Kuida® brand increases its presence in the marketplace and is positioned for future growth.”
Aphria Inc. (TSX: APHA) (NYSE: APHA) is looking into beauty and wellness Internationally, as through its subsidiary Aphria Deutschland GmbH, it recently launched the Company’s first CBD-based nutraceutical, the first product in its CBD-based cosmetics line for the German market. Featuring CBD derived from hemp, the CannRelief brand of products are being produced in the European Union and distributed by the Company’s subsidiary, CC Pharma, which has access to more than 13,000 pharmacies throughout Germany.
CannRelief CBD oils are being sold in both a 5% and 10% CBD concentration and can be found in select stores across Germany. A range of skincare and other products, including creams, serums and masks will be introduced under the CannRelief brand in a phased rollout in 2019. More information about CannRelief products can be found at cannrelief.de.
With the beauty and wellness market expected to have continued growth and consumer mindsets changing, we can expect more cannabis companies to diversify into this area as well as increased interest from large scale retailers, as seen recently from Walmart.
For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks.
Disclaimer: Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this article featuring GCAN is a paid for service on Investorideas.com. Learn more about costs and services https://www.investorideas.com/News-Upload/
Global investors must adhere to regulations of each country.
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.